BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12540496)

  • 21. Hepatitis B virus and the prevention of primary cancer of the liver.
    Blumberg BS; London WT
    J Natl Cancer Inst; 1985 Feb; 74(2):267-73. PubMed ID: 2983134
    [No Abstract]   [Full Text] [Related]  

  • 22. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis B and the prevention of hepatocellular carcinoma].
    Blumberg BS
    Nouv Presse Med; 1982 Mar; 11(12):903-5. PubMed ID: 6278399
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis B leading to hepatocellular carcinoma: calculating the risk.
    Puliyel JM; Taneja V; Jindal K; Thomas N
    Indian J Gastroenterol; 2001; 20(6):251-2. PubMed ID: 11817790
    [No Abstract]   [Full Text] [Related]  

  • 25. Global status of hepatitis B immunisation.
    Kane MA
    Lancet; 1996 Sep; 348(9029):696. PubMed ID: 8806283
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of hepatocellular carcinoma by immunization. A WHO meeting.
    A WHO Meeting
    Bull World Health Organ; 1983; 61(5):731-44. PubMed ID: 6317213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing infection-associated cancer: from bench to hillside.
    Goedert JJ
    J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatocellular carcinoma (HCC): a global perspective.
    Ferenci P; Fried M; Labrecque D; Bruix J; Sherman M; Omata M; Heathcote J; Piratsivuth T; Kew M; Otegbayo JA; Zheng SS; Sarin S; Hamid SS; Modawi SB; Fleig W; Fedail S; Thomson A; Khan A; Malfertheiner P; Lau G; Carillo FJ; Krabshuis J; Le Mair A;
    J Clin Gastroenterol; 2010 Apr; 44(4):239-45. PubMed ID: 20216082
    [No Abstract]   [Full Text] [Related]  

  • 29. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention.
    Koshiol J; Liu Z; O'Brien TR; Hildesheim A
    Cancer Epidemiol; 2018 Apr; 53():195-199. PubMed ID: 29396075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
    Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
    Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Report of the OAU/STRC Ad Hoc Committee on Hepatitis B Vaccination in Africa.
    IARC Sci Publ; 1984; (63):393-401. PubMed ID: 6100277
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology and prevention of hepatocellular carcinoma.
    Franceschi S; Raza SA
    Cancer Lett; 2009 Dec; 286(1):5-8. PubMed ID: 19070421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. We have a cancer vaccine--why don't we use it?
    Hall A
    Trop Med Int Health; 1998 May; 3(5):337-8. PubMed ID: 9623937
    [No Abstract]   [Full Text] [Related]  

  • 37. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH; Wang LY; Hu CT; Huang SC; Huang LC; Lin SS; Chiang YM; Liu TT; Chen CL
    J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Care of the HBV positive mother and her infant.
    Kuhn BS; Cohen SM
    Health Care Women Int; 1986; 7(4):329-40. PubMed ID: 3015858
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis and hepatocellular carcinoma in Southeast Asia.
    Sutnick AI; Nishioka K
    Cancer Detect Prev; 1988; 11(3-6):337-51. PubMed ID: 2839294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatocellular cancer: one of the most cost-effective ways to reduce adult mortality?
    Hall AJ; Smith PG
    Br J Cancer; 1999 Dec; 81(7):1097-8. PubMed ID: 10584866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.